Heilongjiang ZBD Pharmaceutical Co Ltd Capital Reinvestment Ratio
Heilongjiang ZBD Pharmaceutical Co Ltd capital reinvestment ratio. Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥283.54 Million) in capital expenditures (CN¥21.27 Million). Check Heilongjiang ZBD Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)
Capital reinvestment ratio of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025. This chart tracks Heilongjiang ZBD Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore net asset growth rate of Heilongjiang ZBD Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Heilongjiang ZBD Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2011–2025)
Heilongjiang ZBD Pharmaceutical Co Ltd capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see 603567 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥322.10 Million | CN¥68.52 Million | ▼ -81.5% |
| 2024 | 1.15x | CN¥164.31 Million | CN¥189.15 Million | ▼ -79.4% |
| 2020 | 5.60x | CN¥155.18 Million | CN¥868.65 Million | ▲ +591.7% |
| 2019 | 0.81x | CN¥220.92 Million | CN¥178.79 Million | ▼ -29.1% |
| 2018 | 1.14x | CN¥367.40 Million | CN¥419.59 Million | ▲ +97.9% |
| 2017 | 0.58x | CN¥853.19 Million | CN¥492.42 Million | ▼ -97.1% |
| 2016 | 20.14x | CN¥15.83 Million | CN¥318.74 Million | ▲ +9644.1% |
| 2014 | 0.21x | CN¥386.32 Million | CN¥79.85 Million | ▼ -78.6% |
| 2013 | 0.97x | CN¥174.68 Million | CN¥168.73 Million | ▼ -36.1% |
| 2012 | 1.51x | CN¥154.25 Million | CN¥233.09 Million | ▲ +13.2% |
| 2011 | 1.33x | CN¥104.71 Million | CN¥139.77 Million | — |